SOLANA BEACH, Calif., May 10, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic and neurological conditions, today announced that it will be participating in the 2024 Pharma Partnering Summit being held May 14th – 15th in San Diego, California.
Gregory D. Gorgas, President and Chief Executive Officer of Artelo, is scheduled to present on Tuesday, May 14, 2024, at 3:45 p.m. ET / 12:45 p.m. PT. Management will also be hosting meetings with potential partners throughout the summit.
The Pharma Partnering Summit 2024 is an exclusive and one of the most prestigious life sciences deal making international conferences. The platform brings together senior executives and professionals from all over the world focused on business development and licensing, R&D collaborations, commercialization and distribution deals, fundraising, investments, and partnering opportunities.
About Artelo Biosciences
Artelo Biosciences, Inc. is a clinical stage ...